Dornier Flugzeugwerke

Endoluxe Announces Return of Founder Neal Patel, MD as CEO of Company

Retrieved on: 
Tuesday, March 7, 2023

Endoluxe, Inc. announced today the return of founder Neal Patel, MD as CEO of the company following the departure of former CEO Devon Bream.

Key Points: 
  • Endoluxe, Inc. announced today the return of founder Neal Patel, MD as CEO of the company following the departure of former CEO Devon Bream.
  • Endoluxe thanked Devon for his tenure as CEO and for the significant growth he brought to the company since 2021.
  • Having founded Endoluxe in 2014 with Dr. Phil Zhao, Dr. Patel says, “I am incredibly excited to return to my role as CEO of Endoluxe.
  • Endoluxe continues to work closely with Dornier MedTech as its distribution partner for the Endoluxe Visualization System.

ADVANCED MEDTECH ACQUIRES WIKKON, STRENGTHENING ITS MARKET LEADING POSITION IN UROLOGY MEDICAL DEVICES

Retrieved on: 
Tuesday, September 13, 2022

Integrated urology leaderAdvanced MedTech Holdings (AMTH or the Group) announced the acquisition of a majority interest in WIKKON, the Chinese market leader in urology and shock wave therapy devices.

Key Points: 
  • Integrated urology leaderAdvanced MedTech Holdings (AMTH or the Group) announced the acquisition of a majority interest in WIKKON, the Chinese market leader in urology and shock wave therapy devices.
  • Abel Ang, Group Chief Executive of Advanced MedTech, said: We are now uniquely placed to aggressively grow in Chinas sizeable market, which is best served by domestically produced devices.
  • Advanced MedTech Holdings is a global medical technology leader with a core focus in urology devices and contract manufacturing services.
  • Advanced MedTech Holdings makes strategic investments in disruptive medical technology companies, strengthening its portfolio of healthcare solutions for customers around the world.

Endoluxe Enters Into Multi-year USA Distribution Agreement With Dornier MedTech for Urology Segment

Retrieved on: 
Thursday, June 9, 2022

Endoluxe is pleased to announce that they have entered into a multi-year exclusive distribution agreement specifically for the urology market with Dornier MedTech.

Key Points: 
  • Endoluxe is pleased to announce that they have entered into a multi-year exclusive distribution agreement specifically for the urology market with Dornier MedTech.
  • Dornier and Endoluxe have products and platforms focused in the urology arena offering innovation and value.
  • We are absolutely ecstatic to partner with Dornier MedTech to address the growing demands for better imaging solutions in urology, states CEO Devon Bream.
  • With the various new urology products that Dornier introduced at AUA, it is an ideal situation to have Endoluxe join our portfolio of market leading urology products, states Brock Faulkner, CEO of Dornier MedTech America.

Endoluxe to Exhibit With Dornier Medtech During American Urology Association Conference in New Orleans May 13-16, 2022

Retrieved on: 
Thursday, April 7, 2022

Endoluxe is proud to announce that they will be part of the Dornier MedTech exhibition booth during the upcoming AUA conference in New Orleans.

Key Points: 
  • Endoluxe is proud to announce that they will be part of the Dornier MedTech exhibition booth during the upcoming AUA conference in New Orleans.
  • Dornier and Endoluxe have products and platforms focused in the urology arena offering innovation and value.
  • With the various new innovative urology products that Dornier is introducing at AUA, it is an ideal situation to have Endoluxe join our exhibit, states Brock Faulkner, general manager of Dornier MedTech.
  • Dornier MedTech is a medical device company headquartered in Munich, Germany, and is a full subsidiary of Advanced MedTech.

World’s largest kidney stone patient experience survey finds 60% of respondents experienced first kidney stone before the age of 45

Retrieved on: 
Monday, February 7, 2022

Millennials are getting kidney stones, with 60% of patients developing their first stone under the age of 45

Key Points: 
  • Millennials are getting kidney stones, with 60% of patients developing their first stone under the age of 45
    Dornier MedTech (Dornier) is marking World Kidney Stone Day today with the launch of the 2022 Global Urology Survey report the worlds largest survey of kidney stone patient experience.
  • 60% of kidney stone patients responding to the survey indicated that they experienced their first stone before the age of 45, indicating that the millennial age group is moving into its stone-forming years.
  • For kidney stone patients, the need for stents is one of their biggest considerations when choosing treatment options.
  • Urologists are a key touchpoint in a kidney stone patients journey, especially for recurrent stone formers who require regular consultations and treatments.

ZeroAvia Expands its Hydrogen-Electric Aviation Program to 19-Seat Aircraft and Raises Additional $13 Million in Funding for Large Engine Development

Retrieved on: 
Tuesday, June 29, 2021

ZeroAvia secures two Dornier 228 aircraft for the next phase of its research and development for clean hydrogen-electric aviation.

Key Points: 
  • ZeroAvia secures two Dornier 228 aircraft for the next phase of its research and development for clean hydrogen-electric aviation.
  • The 19-seat program will take place at the company's newest facility in Kemble, UK, with additional support from its Hollister, CA location.
  • The company will utilize two twin-engine 19-seat Dornier 228 aircraft - one in the UK and one in the US, provided respectively by Aurigny and AMC Aviation .
  • This new funding complements the initial investment of $24 million the company announced a few weeks ago, bringing the total private investment into ZeroAvia large engine development for 50+ seat aircraft to $37 million.

ZeroAvia Expands its Hydrogen-Electric Aviation Program to 19-Seat Aircraft and Raises Additional $13 Million in Funding for Large Engine Development

Retrieved on: 
Tuesday, June 29, 2021

ZeroAvia secures two Dornier 228 aircraft for the next phase of its research and development for clean hydrogen-electric aviation.

Key Points: 
  • ZeroAvia secures two Dornier 228 aircraft for the next phase of its research and development for clean hydrogen-electric aviation.
  • The 19-seat program will take place at the company's newest facility in Kemble, UK, with additional support from its Hollister, CA location.
  • The company will utilize two twin-engine 19-seat Dornier 228 aircraft - one in the UK and one in the US, provided respectively by Aurigny and AMC Aviation .
  • This new funding complements the initial investment of $24 million the company announced a few weeks ago, bringing the total private investment into ZeroAvia large engine development for 50+ seat aircraft to $37 million.

Extracorporeal Shockwave Device Global Market Insights (2020 to 2025) - Analysis and Forecasts

Retrieved on: 
Friday, December 18, 2020

16.1.4 Dornier Medtech extra corporeal Shockwave Device sales, Revenue, Price and Gross Margin (2015-2020)

Key Points: 

16.1.4 Dornier Medtech extra corporeal Shockwave Device sales, Revenue, Price and Gross Margin (2015-2020)
16.3 Electro Medical Systems (Ems) S.A.
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Dornier MedTech Launches UroX, a new community to boost innovation in the field of urology

Retrieved on: 
Thursday, August 6, 2020

Dornier MedTech is headquartered in Munich, Germany, and is a full subsidiary of Advanced MedTech.

Key Points: 
  • Dornier MedTech is headquartered in Munich, Germany, and is a full subsidiary of Advanced MedTech.
  • Advanced MedTech Holdings is a global medical technology leader with a core focus in urology devices and services.
  • Advanced MedTech Holdings makes strategic investments in disruptive medical technology companies, strengthening its portfolio of healthcare solutions for customers around the world.
  • The National Health Innovation Centre Singapore provides the publicly-funded clinical research sector of Singapore with translational funding and strategic guidance to accelerate healthcare innovation.

Dornier MedTech to Launch New AXIS™ Single-Use Flexible Digital Ureteroscope and Stone Management Products at American Urology Association Annual Meeting

Retrieved on: 
Thursday, April 25, 2019

ATLANTA, April 25, 2019 /PRNewswire/ -- Dornier MedTech (Dornier), a global urology company and a leader in kidney stone management, today announced the launch and immediate availability of its new AXIS Single-Use Digital Flexible Ureteroscope (AXIS) and Stone Management Products in the United States.

Key Points: 
  • ATLANTA, April 25, 2019 /PRNewswire/ -- Dornier MedTech (Dornier), a global urology company and a leader in kidney stone management, today announced the launch and immediate availability of its new AXIS Single-Use Digital Flexible Ureteroscope (AXIS) and Stone Management Products in the United States.
  • The products will be showcased at the upcoming 2019 American Urology Association Meeting in Chicago on 3 - 5 May 2019.
  • A premium product, AXIS offers unmatched image quality and clear visualization for urologists as they perform flexible ureteroscopy.
  • Previews of the new AXIS Single-Use Flexible Digital Ureteroscope and Stone Management Products will take place at the Dornier MedTech booth, #3207.